Showing 1 - 3 results of 3 for search 'Sophia R. Majeed', query time: 0.02s Refine Results
  1. 1
    609 Phase 1/2a dose selection of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced solid malignancies

    609 Phase 1/2a dose selection of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced solid malignancies by Maike Schmidt, Sariah Kell, Dylan M Glatt, Sophia R Majeed

    Published 2023-11-01
    Article
  2. 2
    619 First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: updated phase 1 results

    619 First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: updated phase 1 results by Shivaani Kummar, Drew Rasco, Scott A Laurie, Dylan M Glatt, Sophia R Majeed, Albiruni Abdul Razak, Anh Diep

    Published 2023-11-01
    Article
  3. 3
    23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function

    23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function by Jill Fenaux, Xin Fang, Yao-ming Huang, Cristina Melero, Caroline Bonnans, Earth Light Lowe, Tiziana Palumbo, Cecilia Lay, Zuoan Yi, Aileen Zhou, Mauro Poggio, Wei-Jen Chung, Sophia R. Majeed, Dylan Glatt, Alice Chen, Maike Schmidt, Clarissa C. Lee

    Published 2023-12-01
    Get full text
    Article

Search Tools: